Details for Patent: 8,410,086
✉ Email this page to a colleague
Which drugs does patent 8,410,086 protect, and when does it expire?
Patent 8,410,086 protects VASCEPA and is included in one NDA.
This patent has sixty-nine patent family members in twenty-six countries.
Summary for Patent: 8,410,086
Title: | Compositions and methods for lowering triglycerides |
Abstract: | In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. |
Inventor(s): | Osterloh; Ian (Kent, GB), Wicker; Pierre (Mystic, CT), Braeckman; Rene (Richboro, PA), Soni; Paresh (Mystic, CT), Manku; Mehar (England, GB) |
Assignee: | Amarin Pharmaceuticals Ireland Limited (Dublin, IE) |
Application Number: | 13/272,520 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,410,086 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 8,410,086
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE OF VASCEPA TO LOWER TRIGLYCERIDES AND LDL-C IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE (TG) LEVELS (ABOUT 200 MG/DL TO LESS THAN ABOUT 500 MG/DL) AND ON STATIN THERAPY | ⤷ Sign Up | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | USE OF VASCEPA TO LOWER TRIGLYCERIDES AND LDL-C IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE (TG) LEVELS (ABOUT 200 MG/DL TO LESS THAN ABOUT 500 MG/DL) AND ON STATIN THERAPY | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,410,086
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2443246 | ⤷ Sign Up | 301137 | Netherlands | ⤷ Sign Up |
European Patent Office | 2443246 | ⤷ Sign Up | LUC00226 | Luxembourg | ⤷ Sign Up |
European Patent Office | 2443246 | ⤷ Sign Up | PA2021522 | Lithuania | ⤷ Sign Up |
European Patent Office | 2443246 | ⤷ Sign Up | 2021C/538 | Belgium | ⤷ Sign Up |
European Patent Office | 2443246 | ⤷ Sign Up | 122021000056 | Germany | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |